dual glp-1/gip receptor agonists The Sustained Effects of a GIP/GLP-1 Agonist, NNC0090-2746, in Patients with Type 2 Diabetes: Cell Metabolism Roche's CT-388 Adds Optionality In
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13





























